Isobutyl-1-(4-(N'-(isobutoxycarbonyl)carbamimidoyl)benzyl)-8-(1-(pyrrolidine-1-carbonyl)cyclopentyl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazine-2(1H)-carboxylate

ID: ALA3908646

Max Phase: Preclinical

Molecular Formula: C38H50N6O5

Molecular Weight: 670.86

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)COC(=O)/N=C(\N)c1ccc(CC2c3nc4cc(C5(C(=O)N6CCCC6)CCCC5)ccc4n3CCN2C(=O)OCC(C)C)cc1

Standard InChI:  InChI=1S/C38H50N6O5/c1-25(2)23-48-36(46)41-33(39)28-11-9-27(10-12-28)21-32-34-40-30-22-29(38(15-5-6-16-38)35(45)42-17-7-8-18-42)13-14-31(30)43(34)19-20-44(32)37(47)49-24-26(3)4/h9-14,22,25-26,32H,5-8,15-21,23-24H2,1-4H3,(H2,39,41,46)

Standard InChI Key:  SPPPFIZBKGKIJC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 49 54  0  0  0  0  0  0  0  0999 V2000
    9.8876  -10.7514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6021  -11.1639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8876   -9.9264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3165  -10.7514    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3165   -9.9264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6021   -9.5138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1030  -11.0063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6181  -10.3388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1030   -9.6714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7674   -8.9178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9470   -8.8315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4620   -9.4990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7976  -10.2526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0311  -11.1639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0311  -11.9889    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7229  -10.7145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6416   -9.4127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8570   -9.1578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3720   -9.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8570  -10.4927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6416  -10.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8131   -8.6058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5833   -8.3101    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1720   -8.0866    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3751   -8.3001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9258   -7.6082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4449   -6.9670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2151   -7.2627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6021  -11.9889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8876  -12.4013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1731  -11.9889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4587  -12.4013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4587  -13.2263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1731  -13.6389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8876  -13.2263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7442  -13.6389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7442  -14.4639    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0524  -13.1895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3172  -13.5641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2741  -14.3879    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6253  -13.1148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8903  -13.4892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1983  -13.0400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2415  -12.2161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4633  -13.4145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4580  -11.0891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1499  -10.6397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1067   -9.8159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8850  -11.0143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  3  6  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
  8 13  2  0
  9 10  2  0
  3  9  1  0
  1  7  2  0
 14 15  2  0
 14 16  1  0
  4 14  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 17 21  1  0
 22 23  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 24 28  1  0
 22 24  1  0
 17 22  1  0
 12 17  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 30 35  2  0
 36 37  1  0
 36 38  2  0
 39 40  2  0
 42 43  1  0
 43 44  1  0
 43 45  1  0
 41 42  1  0
 39 41  1  0
 38 39  1  0
 33 36  1  0
  2 29  1  0
 46 47  1  0
 47 48  1  0
 47 49  1  0
 16 46  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3908646

    ---

Associated Targets(non-human)

thrombin Thrombin (80 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 670.86Molecular Weight (Monoisotopic): 670.3843AlogP: 6.36#Rotatable Bonds: 9
Polar Surface Area: 132.35Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 4.74CX LogP: 6.17CX LogD: 6.17
Aromatic Rings: 3Heavy Atoms: 49QED Weighted: 0.21Np Likeness Score: -0.74

References

1. Chen D, Shi J, Liu J, Zhang X, Deng X, Yang Y, Cui S, Zhu Q, Gong G, Xu Y..  (2017)  Design, synthesis and antithrombotic evaluation of novel non-peptide thrombin inhibitors.,  25  (2): [PMID:27884512] [10.1016/j.bmc.2016.11.012]

Source